论文部分内容阅读
将78例非小细胞肺癌(N SCLC)患者随机分为化疗组和联合组(化疗+康艾注射液),化疗3~4周期,停用1个月后评价疗效。联合组总获益率明显高于化疗组(P<0.01),白细胞下降及肝功能受损发生率明显低于化疗组(P<0.05)。提示康艾注射液联合化疗能提高N SCLC疗效,降低药物毒性反应。
A total of 78 patients with non-small cell lung cancer (N SCLC) were randomly divided into chemotherapy group and combination group (Chemotherapy + Kang AI injection). The chemotherapy was performed for 3 to 4 cycles. The total benefit rate in combination group was significantly higher than that in chemotherapy group (P <0.01), and the incidence of leukopenia and hepatic dysfunction was significantly lower than that in chemotherapy group (P <0.05). Prompt Kangai injection combined with chemotherapy can improve the efficacy of N SCLC, reduce drug toxicity.